Assessment of ‘Cancer-prone Personality' Characteristics in Healthy Study Subjects and in Patients with Breast Disease and Breast Cancer Using the Commitment Questionnaire: A Prospective Case–Control Study in Finland (2024)

Research ArticleClinical Studies

MATTI ESKELINEN and PAULA OLLONEN

Anticancer Research November 2011, 31 (11) 4013-4017;

Abstract

Background: The findings of a repressed expression of emotions in cancer patients contributed to the hypothesis developed by Lydia Temoshok of a type C personality (‘cancer-prone’). To the Authors' knowledge, the associations between the ‘cancer-prone personality’ characteristics in commitment test and the risk of breast cancer (BC) have rarely been considered together in a prospective study. Patients and Methods: In an extension of the Kuopio Breast Cancer Study, 115 women with breast symptoms were evaluated for commitment test before any diagnostic procedures were carried out. Results: The clinical examination and biopsy showed BC in 34 patients, benign breast disease (BBD) in 53 patients and 28 individuals were shown to be healthy study subjects (HSS). The BC group reported significantly more commitment to own children (Function A) (mean Commitment score, 3.14) than the patients in the BBD group (mean Commitment score, 3.51) and in the HSS group (mean Commitment score, 3.77) (p=0.05). The women in the BC group also reported more commitment to own husband (Function B) (mean Commitment score, 3.30) than the patients in the BBD group (mean Commitment score, 3.83) and the patients in the HSS group (mean Commitment score, 3.76). The BC group reported significantly more commitment to own work and own body (Function D and G) (mean Commitment scores, 3.20 and 3.50) than the patients in the BBD group (mean Commitment scores, 3.75 and 3.71) or HSS group (mean Commitment scores, 3.46 and 3.50). The mean sum (mean, SD) of the scores were significantly lower in the BC group (31.1, 5.8) than in the BBD (35.2, 6.9) and HSS group (36.4, 5.6) (p=0.02), showing more commitment in the BC group. Conclusion: In summary, patients with BC tended to have an increased risk for bearing the ‘high commitment’ characteristic and this pattern could contribute to cancer risk through immune and hormonal pathways.

According to Temoshok's theoretical model (1, 2), the main personality factors increasing breast cancer (BC) risk are suppression of emotions and coping style characterized by a tendency to defer one's own needs to the needs of others (commitment). The early findings of a repressed expression of emotions in cancer patients contributed to the hypothesis developed by Lydia Temoshok of a type C personality bearing these findings (1, 2). Because BC is a hormonally responsive neoplasm and one with great psychological impact, it has been the most extensively investigated tumour for possible psychological variables associated with risk and survival (3). Hormonal factors, such as early age at menarche, later age at menopause, later age at first full-term pregnancy and hormone replacement therapy, are known to be the main risk factors for sporadic BC (4). In addition, life-style factors, such as obesity, smoking, alcohol consumption and lack of physical activity, appear to contribute to an increased risk for this malignancy, although the results concerning such factors are inconsistent (4-10). Psychological factors, such as stressful and adverse life events, are widely thought to play a role in the aetiology of BC (11-30). To the Authors' knowledge, the associations between ‘cancer-prone’ personality characteristics in a commitment test and the risk of breast cancer are rarely considered together, and therefore this was a prospective study to examine the role of the ‘cancer-prone’ personality characteristics in a commitment test in women with breast symptoms referred by physicians to the Kuopio University Hospital (Finland).

View this table:

Table I.

Characteristics of the study participants. Results are shown for the patients with breast cancer (BC), for those with benign breast disease (BBD) and for the healthy study participants (HSS).

Patients and Methods

The Kuopio Breast Cancer Study was a multidisciplinary cooperative project conducted by different departments of the University of Kuopio and Kuopio University Hospital, and included all women who were referred to the hospital for breast examination between April 1990 and December 1995. The Kuopio Breast Cancer Study followed the protocol of the International Collaborative Study of Breast and Colorectal Cancer coordinated by the European Institute of Oncology in Milan, and was initiated as a SEARCH program of the International Agency for Research on Cancer. The collaborative study is based on the assumption that breast cancer and colorectal cancer may have common risk factors. Study centers for the breast cancer study are situated in Canada, Finland, Greece, Ireland, Italy, Russia, Slovakia, Spain and Switzerland (31). The study participants showed breast cancer symptoms (a lump in the breast or in the axilla, pain in the breast, bleeding from the nipple, nipple discharge and/or skin dimpling), or an abnormality of the breast, and the indications for referral in this study were in line with our previous investigations in a Breast Cancer Diagnostic Unit in Finland (32).

This case–control study was an extension of the Kuopio Breast Cancer Study (33, 34) and was approved by the Joint Committee of the University of Kuopio and Kuopio University Hospital. The women referred from January 1991 to June 1992 were included. Participation was based on written consent. One hundred and fifteen women participated and were interviewed (to determine the level of emotional depression) by a psychiatrist (P.O.) before any diagnostic procedures, so neither the interviewer nor the patient knew the diagnosis at the time of the interview. The interviews were recorded and the ratings were completed before the final diagnosis. The clinical examination, mammography and biopsy showed BC in 34 (29.6%) patients, benign breast disease (BBD) in 53 (46.1%) patients and 28 (23.4) patients with healthy study subjects (HSS) (Table I).

Commitment questionnaire (CQ). The women completed the Commitment questionnaire with nine key questions which attempt to elucidate the commitment characteristics. The commitment characteristics were assessed for the HSS, BBD and BC groups on a five- point scale: grade I (1 point) indicating high commitment characteristics, and grade V (5 points) low commitment characteristics.

Statistical analysis. Significance of the results was calculated with the SPSS/PC statistical package (SPSS Inc., Chicago, IL, USA). Correlations and differences between the study groups (BC, BBD and HSS groups) were measured with the two-sided Chi-square test and non-parametric Kruskal-Wallis variance analyses. Results were considered statistically significant at a p-value <0.05.

Results

The mean age of the BC patients was 51.5 years. The corresponding figure for the patients with BBD was 47.5 years and for the HSS group 45.7 years. Although the patients in the BC group were older than those in the BBD and HSS groups, the age difference was not statistically significant (p=0.12). The majority of the patients (85/115, 74%) were married or living in a steady relationship. Almost half of the patients (41.7%) had graduated from primary school, and 25% had a college education. By profession, the patients represented industrial and service employees (25.2%), office employees (10.4%), health care employees (8.7%) and farmers (8.7%) and almost 23.5% were retired. The combined mean gross income of both spouses in the patients with BC was 36,100 € per year. The corresponding figures for the patients with BBD were 27,714 € per year and for the healthy study subjects (HSS) were 24,521 € per year. The patients with BC weresignificantly (p=0.03) wealthier than the patients with BBD and HSS, as estimated by the combined gross income of both spouses. The groups differed only slightly from each other as to the factors of the reproductive life of the women (Table I).

Figure 1.

The distribution of the mean sum of the Commitment Scores in nine separate categories, for the healthy study participants (HSS), for those with benign breast disease (BBD) and for patients with breast cancer (BC). A, Commitment to own children, p=0.05; B, Commitment to own husband, p=0.05; C, Commitment to own parents, p=0.52; D, Commitment to work, p=0.06; E, Commitment to free time, p=0.50; F, Commitment to sexuality, p=0.22; G, Commitment to own body, p=0.05; H, Commitment to own breast, p=0.19; I, Commitment to normativity, p=0.36.

The distribution of the Commitment Score. The distribution of the mean sum of the Commitment Scores in nine separate categories, for HSS, BBD and BC groups are shown in Figure 1. The BC group reported significantly more commitment to own children (Function A) (mean Commitment Score, 3.14) than the patients in the BBD group (mean Commitment Score, 3.51) and in the HSS group (mean Commitment Score, 3.77) (p=0.05). The women in the BC group also reported more commitment to own husband (Function B) (mean Commitment Score, 3.30) than the patients in the BBD group (mean Commitment Score, 3.83) and the patients in the HSS group (mean Commitment Score, 3.76). The BC group reported significantly more commitment to own work and own body (Function D and G) (mean Commitment Scores, 3.20 and 3.50) than the patients in the BBD group (mean Commitment Scores, 3.75 and 3.71) or HSS group (mean Commitment Scores, 3.46 and 3.50). The mean sum (mean, SD) of the scores of the Commitment test variables were significantly lower in the BC group (31.1, 5.8) than in the BBD (35.2, 6.9) and HSS group (36.4, 5.6) (p=0.02).

Discussion

Lydia Temoshok noted the absence of theoretical constructs in psychosocial research and proposed the type C personality, using concepts from the personality types A and B originally constructed for research on the relationship between life stress and cardiovascular disease (35). Temoshok's type C personality maintains emotional control and pleasant interpersonal relations despite internal unexposed distress (1, 2). The type C person (‘cancer–prone’ person) copes with stressful life changes and loss by depressive symptoms, suppression of emotions and coping style characterized by a tendency to defer one's own needs to the needs of others (commitment). Personality as risk factor for developing cancer via a ‘cancer-prone personality’ remains debatable, but this pattern could contribute to cancer risk through immune and hormonal pathways. The focus of this study was to investigate the coping style characterized by a tendency to defer one's own needs to the needs of others in HSS, in BBD and BC patients.

It has been shown that caring for disabled older adults causes adverse effects on caregivers' health, such as anxiety and depression. Subjective burden mediates this relationship and therefore resolving subjective burden leads to prevention of the negative effects of caring for disabled older adults (36). Theoretical models that try to explain the stress in care–giving are often based on the stress model by Folkman and Lazarus (37). Stress related to care giving outcomes is determined by factors such as social support and coping. Subjective burden is associated with several factors such as approach coping skills, avoidance coping, emotion-focused coping, problem-focused coping, and control of negative thoughts (36). Avoidance coping is positively associated with subjective burden in home caregivers of older relatives with cognitive impairment. Emotion–focused coping could be a mix of coping categories and approach coping and problem–focused coping depend on stressor type (36).

From the popular belief that psychological factors have a significant role in the carcinogenesis of the breast, it follows that study subjects with breast cancer may be more prone than healthy subjects to report prior stress and other psychological problems in an effort to explain their BC. This could lead either to a false–positive association between psychological factors and BC risk or to the overestimation of true positive associations. Therefore, the study was designed to reduce the recall bias; the reports on psychological factors were obtained from the study subjects who had BC symptoms, but had not yet been given a definitive diagnosis.

The subjects in the BC group were significantly more committed to their own children, husband and own body than the subjects in the BBD and HSS groups. The mean sum of the scores of the Commitment test variables were significantly lower in the BC group than in the BBD and HSS groups, showing more commitment in BC group. To our knowledge, there are no previous reports with this study design available for sufficient comparative evaluation and to examine the role of the Commitment test in HSS, BBD and BC groups. Scherg (38) studied 75 women with BC prospectively comparing them to 75 benign controls, matched in pairs for age and reason for consultation, and found that the BC patients put off their own wishes in favour of a more social behaviour in the Social Desirability scale. Scherg also noted that the awareness of BC can mask an association between psychosocial scales and BC risk and proposed that an appropriate control group is crucial in order to avoid bias.

One potential bias arises from age being a confounding factor, and some of the earlier studies have been critized on such methodological grounds as limited controlling for age (39). In the present study, the BC group was 4.0 years and 5.9 years older than the BBD group and the HSS group, respectively. However, no statistically significant age difference between these groups was found in our study (p=0.12).

In summary, the results of this study do not support a specific link between ‘cancer-prone personality’ characteristics in general and breast cancer risk. Although, the patients with BC tended to have a risk for ‘high commitment’ characteristics, the personality as risk factor for developing cancer via a ‘cancer-prone personality’ remains debatable, and this pattern could contribute to cancer risk through immune and hormonal pathways.

Acknowledgements

We thank Ms A.K. Lyytinen, R.N. for help in data collection. The support from the Academy of Finland, Paavo Koistinen Foundation and EVO funds from Kuopio University Hospital are gratefully acknowledged.

  • Received August 4, 2011.
  • Revision received September 23, 2011.
  • Accepted September 28, 2011.
  • Copyright© 2011 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

References

    1. Temoshok L,
    2. Heller BW,
    3. Sagebiel RW,
    4. Blois MS,
    5. Sweet DM,
    6. DiClemente RJ,
    7. Gold ML

    : The relationship of psychosocial factors to prognostic indicators in cutaneous malignant melanoma. J Psychosomatic Res 29: 139-154, 1985.

    1. Temoshok L

    : Personality, coping style, emotion and cancer: towards an integrative model. Cancer Surv 6: 545-567, 1987.

    1. McKenna MC,
    2. Zevon MA,
    3. Corn B,
    4. Rounds J

    : Psychosocial factors and the development of breast cancer: a meta-analysis. Health Psychol 18: 520-531, 1999.

    1. Key JA,
    2. Verkasalo PK,
    3. Banks E

    : Epidemiology of breast cancer. Lancet Oncol 2: 133-140, 2001.

    1. Mitrunen K,
    2. Hirvonen A

    : Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism. Mutat Res 544: 9-41, 2003.

    1. Männistö S,
    2. Pietinen P,
    3. Pyy M,
    4. Palmgren J,
    5. Eskelinen M,
    6. Uusitupa M

    : Body-size indicators and risk of breast cancer according to menopause and estrogen-receptor status. Int J Cancer 68: 8-13, 1996.

    1. Mitrunen K,
    2. Kataja V,
    3. Eskelinen M,
    4. Kosma VM,
    5. Kang D,
    6. Benhamou S,
    7. Vainio H,
    8. Uusitupa M,
    9. Hirvonen A

    : Combined COMT and GST genotypes and hormone replacement therapy associated breast cancer risk. Pharmacogenetics 12: 67-72, 2002.

    1. Eskelinen M,
    2. Norden T,
    3. Lindgren A,
    4. Wide L,
    5. Adami HO,
    6. Holmberg L

    : Preoperative serum levels of follicle-stimulating hormone (FSH) and prognosis in invasive breast cancer. Eur J Surg Oncol 30: 495-500, 2004.

    1. Sillanpää P,
    2. Hirvonen A,
    3. Kataja V,
    4. Eskelinen M,
    5. Kosma V-M,
    6. Uusitupa M,
    7. Vainio H,
    8. Mitrunen K

    : NAT2 slow acetylator genotype as an important modifier of breast cancer risk. Int J Cancer 114: 579-584, 2005.

    1. Sillanpää P,
    2. Kataja V,
    3. Eskelinen M,
    4. Kosma V-M,
    5. Uusitupa M,
    6. Vainio H,
    7. Mitrunen K,
    8. Hirvonen A

    : Sulfotransferase 1A1 genotype as a potential modifier of breast cancer risk among premenopausal women. Pharmacogenetics 15: 749-752, 2005.

    1. Chen CC,
    2. David AS,
    3. Nunnerley H,
    4. Michell M,
    5. Dawson JL,
    6. Berry H,
    7. Dobbs J,
    8. Fahy T

    : Adverse life events and breast cancer: case–control study. BMJ 311: 1527-1530, 1995.

    1. Roberts FD,
    2. Newcomb PA,
    3. Trentham-Dietz A,
    4. Storer BE

    : Self-reported stress and risk of breast cancer. Cancer 77: 1089-1093, 1996.

    1. Protheroe D,
    2. Turvey K,
    3. Horgan K,
    4. Benson E,
    5. Bowers D,
    6. House A

    : Stressful life events and difficulties and onset of breast cancer: case–control study. BMJ 319: 1027-1030, 1999.

    1. Price MA,
    2. Tennant CC,
    3. Butow PN,
    4. Smith RC,
    5. Kennedy SJ,
    6. Kossoff MB,
    7. Dunn SM

    : The role of psychosocial factors in the development of breast carcinoma: Part II. Life event stressors, social support, defense style, and emotional control and their interactions. Cancer 91: 686-697, 2001.

    1. Duijts SFA,
    2. Zeegers MPA,
    3. VD Borne B

    : The association between stressful life events and breast cancer risk: a meta-analysis. Int J Cancer 107: 1023-1029, 2003.

    1. Ginzburg K,
    2. Wrensch M,
    3. Rice T,
    4. Farren G,
    5. Spiegel D

    : Breast cancer and psychosocial factors: early stressful life events, social support, and well-being. Psychosomatics 49: 407-412, 2008.

    1. Ollonen P,
    2. Lehtonen J,
    3. Eskelinen M

    : Stressful and adverse life experiences in patients with breast symptoms; a prospective case–control study in Kuopio, Finland. Anticancer Res 25: 531-536, 2005.

    1. Ollonen P,
    2. Lehtonen J,
    3. Eskelinen M

    : Anxiety, depression and the history of psychiatric symptoms in patients with breast disease: A prospective case–control study in Kuopio, Finland. Anticancer Res 25: 2527-2534, 2005.

    1. Ollonen P,
    2. Lehtonen J,
    3. Eskelinen M

    : Coping and defending as risk factors for breast cancer in patients with breast disease: a prospective case–control study in Kuopio, Finland. Anticancer Res 25: 4623-4630, 2005.

    1. Ollonen P,
    2. Eskelinen M

    : Idealization as risk factor for breast cancer in patients with breast disease: a prospective case–control study in Kuopio, Finland. Anticancer Res 27: 1625-1630, 2007.

    1. Eskelinen M,
    2. Ollonen P

    : Psychosocial risk scale (PRS) for breast cancer in patients with breast disease: a prospective case–control study in Kuopio, Finland. Anticancer Res 29: 4765-4770, 2009.

    1. Eskelinen M,
    2. Ollonen P

    : The body image drawing analysis in women with breast disease and breast cancer: anxiety, colour and depression categories. Anticancer Res 30: 683-691, 2010.

    1. Eskelinen M,
    2. Ollonen P

    : Evaluation of women with breast disease using body image drawing analysis. Anticancer Res 30: 2399-2406, 2010.

    1. Eskelinen M,
    2. Ollonen P

    : Life stress due to losses and deficit in childhood and adolescence as breast cancer risk factor: a prospective case–control study in Kuopio, Finland. Anticancer Res 30: 4303-4308, 2010.

    1. Eskelinen M,
    2. Ollonen P

    : Life stress and losses and deficit in adulthood as breast cancer risk factor: a prospective case–control study in Kuopio, Finland. In Vivo 24: 899-904, 2010.

    1. Eskelinen M,
    2. Ollonen P

    : Beck Depression Inventory (BDI) in patients with breast disease and breast cancer: a prospective case–control study. In Vivo 25: 111-116, 2011.

    1. Eskelinen M,
    2. Ollonen P

    : Forsen Psychological Risk Inventory for breast cancer patients: a prospective case–control study with special reference to the use of psychiatric medications. Anticancer Res 31: 739-744, 2011.

    1. Eskelinen M,
    2. Ollonen P

    : Montgomery-Asberg depression rating scale (MADRS) in healthy study subjects, in patients with breast disease and breast cancer: a prospective case–control study. Anticancer Res 31: 1065-1069, 2011.

    1. Eskelinen M,
    2. Ollonen P

    : Assessment of general anxiety in patients with breast disease and breast cancer using the Spielberger STAI self evaluation test: a prospective case–control study in Finland. Anticancer Res 31: 1801-1806, 2011.

    1. Forsen A

    : Psychosocial stress as a risk of breast cancer. Psychother Psychosom 55: 176-185, 1991.

    1. Boyle P

    : SEARCH programme of the International Agency for Research on Cancer. Eur J Cancer 26: 547-549, 1990.

    1. Eskelinen M,
    2. Collan Y,
    3. Leivonen M,
    4. Hertsi M,
    5. Valkamo E,
    6. Puittinen J,
    7. Karosto R

    : Detection of breast cancer. A study of women with breast cancer symptoms. Theor Surg 3: 111-117, 1988.

    1. Mitrunen K,
    2. Jourenkova N,
    3. Kataja V,
    4. Eskelinen M,
    5. Kosma VM,
    6. Benhamou S,
    7. Vainio H,
    8. Uusitupa M,
    9. Hirvonen A

    : Steroid metabolism gene CYP 17 polymorphism and the development of breast cancer. Cancer Epidemiol Biomarkers Prev 9: 1343-1348, 2000.

    1. Mitrunen K,
    2. Jourenkova N,
    3. Kataja V,
    4. Eskelinen M,
    5. Kosma VM,
    6. Benhamou S,
    7. Vainio H,
    8. Uusitupa M,
    9. Hirvonen A

    : Glutathione-S-transferase M1, M3, P1 and T1 genetic polymorphism and susceptibility to breast cancer. Cancer Epidemiol Biomarkers Prev 10: 229-236, 2001.

    1. Friedman M,
    2. Rosenman RH

    : Overt behavior pattern in coronary disease. Detection of overt behavior pattern A in patients with coronary disease by a new psychophysiological procedure. JAMA 173: 1320-1325, 1960.

    1. Cooper C,
    2. Katona C,
    3. Orrell M,
    4. Livingston G

    : Coping strategies, anxiety and depression in caregivers of people with Alzheimer's disease. Int J Geriatr Psychiatry 23: 929-936, 2008.

    1. Folkman S,
    2. Lazarus RS

    : Coping as a mediator of emotion. J Pers Soc Psychol 54: 466-475, 1988.

    1. Scherg H

    : Psychosocial factors and disease bias in breast cancer patients. Psychosom Med 49: 302-312, 1987.

    1. McGee R

    : Does stress cause cancer? There is no good evidence of a relation between stressful events and cancer. BMJ 319: 1015-1016, 1999.

Back to top

Jump to section

Related Articles

  • No related articles found.

Cited By...

More in this TOC Section

Similar Articles

Assessment of ‘Cancer-prone Personality' Characteristics in Healthy Study Subjects and in Patients with Breast Disease and Breast Cancer Using the Commitment Questionnaire: A Prospective Case–Control Study in Finland (2024)

FAQs

What personality traits make up the cancer prone personality? ›

Cancer-Prone Personality Types

Represses both positive and negative emotions. Shows anger, resentment, or hostility towards others. Takes on extra duties and responsibilities, even when they cause stress. Reacts adversely to and does not cope well with life changes.

What personality traits are associated with breast cancer? ›

Neuroticism and negative affectivity were the strongest associated factors to the risk of the breast cancer group in comparison to the control group. Patients with such a personality profile in groups of increased breast cancer risk should be especially targeted for psychological and social support.

What is cancer prone personality traits? ›

The type C person ('cancer–prone' person) copes with stressful life changes and loss by depressive symptoms, suppression of emotions and coping style characterized by a tendency to defer one's own needs to the needs of others (commitment).

Which type of personality is more prone to cancer? ›

Personality has long been hypothesized to predispose individuals to cancer initiation or progression. The early observation by Kissen and Eysenck (1) that patients with lung cancer may show high levels of extroversion and low levels of neuroticism led to posit a “cancer-prone” personality.

What people are prone to cancer? ›

General risk factors

Age – the risk of developing cancer increases as you get older. Lifestyle factors – these include smoking, your weight, your diet, how active you are, sun exposure and sunbed use, and how much alcohol you drink.

What is cancer strongest trait? ›

Cancer's Best Personality Traits

Compassionate, often sweet, always deeply feeling, and capable of cracking up their inner circle with their offbeat or goofy sense of humor, you can rely on the Cancers in your life to offer a shoulder to cry on and freshly baked cookies.

What characteristics are associated with cancer? ›

Symptoms
  • Fatigue.
  • Lump or area of thickening that can be felt under the skin.
  • Weight changes, including unintended loss or gain.
  • Skin changes, such as yellowing, darkening or redness of the skin, sores that won't heal, or changes to existing moles.
  • Changes in bowel or bladder habits.
  • Persistent cough or trouble breathing.

Top Articles
Latest Posts
Article information

Author: Horacio Brakus JD

Last Updated:

Views: 6548

Rating: 4 / 5 (71 voted)

Reviews: 94% of readers found this page helpful

Author information

Name: Horacio Brakus JD

Birthday: 1999-08-21

Address: Apt. 524 43384 Minnie Prairie, South Edda, MA 62804

Phone: +5931039998219

Job: Sales Strategist

Hobby: Sculling, Kitesurfing, Orienteering, Painting, Computer programming, Creative writing, Scuba diving

Introduction: My name is Horacio Brakus JD, I am a lively, splendid, jolly, vivacious, vast, cheerful, agreeable person who loves writing and wants to share my knowledge and understanding with you.